Author

B. Awakoaiye

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

P. Penaloza-MacMaster· 2 shared S. Fourati· 2 shared T. Dangi· 2 shared J. M. Richner· 1 shared N. Irani· 1 shared S. Sanchez· 1 shared Y. R. Chung· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

P. Penaloza-MacMaster

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation

S. Sanchez, T. Dangi, B. Awakoaiye, N. Irani, S. Fourati, J. M. Richner, P. Penaloza-MacMaster

This study shows that administering 4-1BB costimulatory antibodies after 96 hours post-mRNA vaccination enhances CD8 T cell responses and protection against breakthrough infections.

bioRxiv · Mar 1, 2024 · PreprintImmunology

Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-I

Y. R. Chung, B. Awakoaiye, T. Dangi, S. Fourati, P. Penaloza-MacMaster

This study shows that replication-attenuated r3LCMV vectors enhance tumor control and survival in multiple tumor models, including immunodeficient mice, through IFN-I signaling.

bioRxiv · Dec 8, 2023 · PreprintImmunology